These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 27320333)
1. Retinoid X Receptor Selective Agonists and their Synthetic Methods. Wagner CE; Jurutka PW; Marshall PA; Heck MC Curr Top Med Chem; 2017; 17(6):742-767. PubMed ID: 27320333 [TBL] [Abstract][Full Text] [Related]
2. Modulation of RXR function through ligand design. Pérez E; Bourguet W; Gronemeyer H; de Lera AR Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403 [TBL] [Abstract][Full Text] [Related]
3. Advances in drug design with RXR modulators. Vaz B; de Lera ÁR Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251 [TBL] [Abstract][Full Text] [Related]
4. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action. Brtko J; Dvorak Z Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201 [TBL] [Abstract][Full Text] [Related]
5. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers. Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330 [TBL] [Abstract][Full Text] [Related]
6. Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Széles L; Póliska S; Nagy G; Szatmari I; Szanto A; Pap A; Lindstedt M; Santegoets SJ; Rühl R; Dezsö B; Nagy L Mol Endocrinol; 2010 Nov; 24(11):2218-31. PubMed ID: 20861222 [TBL] [Abstract][Full Text] [Related]
7. Natural and Structure-based RXR Ligand Scaffolds and Their Functions. Dominguez M; Alvarez S; de Lera AR Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335 [TBL] [Abstract][Full Text] [Related]
8. Retinoid X receptor agonists modulate Foxp3⁺ regulatory T cell and Th17 cell differentiation with differential dependence on retinoic acid receptor activation. Takeuchi H; Yokota-Nakatsuma A; Ohoka Y; Kagechika H; Kato C; Song SY; Iwata M J Immunol; 2013 Oct; 191(7):3725-33. PubMed ID: 23980207 [TBL] [Abstract][Full Text] [Related]
9. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells. Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495 [TBL] [Abstract][Full Text] [Related]
10. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Mukherjee R; Davies PJ; Crombie DL; Bischoff ED; Cesario RM; Jow L; Hamann LG; Boehm MF; Mondon CE; Nadzan AM; Paterniti JR; Heyman RA Nature; 1997 Mar; 386(6623):407-10. PubMed ID: 9121558 [TBL] [Abstract][Full Text] [Related]
11. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Seol W; Choi HS; Moore DD Mol Endocrinol; 1995 Jan; 9(1):72-85. PubMed ID: 7760852 [TBL] [Abstract][Full Text] [Related]
12. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode. Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235 [TBL] [Abstract][Full Text] [Related]
13. Ligand Design for Modulation of RXR Functions. Martínez C; Souto JA; de Lera AR Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388 [TBL] [Abstract][Full Text] [Related]
14. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN. Wagner CE; Jurutka PW Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392 [TBL] [Abstract][Full Text] [Related]
15. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein. Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778 [TBL] [Abstract][Full Text] [Related]
16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990 [TBL] [Abstract][Full Text] [Related]
17. [Retinoids: mechanisms of action]. Berbis P Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985 [TBL] [Abstract][Full Text] [Related]
18. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. Kephart DD; Walfish PG; DeLuca H; Butt TR Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites. Boergesen M; Pedersen TÅ; Gross B; van Heeringen SJ; Hagenbeek D; Bindesbøll C; Caron S; Lalloyer F; Steffensen KR; Nebb HI; Gustafsson JÅ; Stunnenberg HG; Staels B; Mandrup S Mol Cell Biol; 2012 Feb; 32(4):852-67. PubMed ID: 22158963 [TBL] [Abstract][Full Text] [Related]
20. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Willy PJ; Umesono K; Ong ES; Evans RM; Heyman RA; Mangelsdorf DJ Genes Dev; 1995 May; 9(9):1033-45. PubMed ID: 7744246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]